Immunosuppressive Agents: all 5,940 studies that test it

Page 30 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.

• Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic LeukemiaStatus unknownNCT04714593Phase 1/2
• Topical Cyclosporine A for the Treatment of Dry Eye: A Randomized Clinical StudyCompletedNCT04714099Phase 3
• A Phase 2 Trial for Patients With Metastatic Solid CancerActive, not recruitingNCT04713371Phase 2
• Sirolimus for Retinal Astrocytic HamartomaCompletedNCT04707209Not applicable
• Novel BCMA-targeted CAR-T Cell Therapy for Multiple MyelomaStatus unknownNCT04706936Phase 1
• Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHLActive, not recruitingNCT04697940Phase 1/2
• ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple SclerosisActive, not recruitingNCT04695080Phase 2/3
• Thalidomide in the Treatment of Chronic Radiation Proctitis With Intractable BleedingStatus unknownNCT04680195Phase 2
• MTX and Steroid for aGVHD TreatmentStatus unknownNCT04677868Phase 2
• CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.Active, not recruitingNCT04667663Phase 1
• Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney TransplantActive, not recruitingNCT04665310Phase 4
• Cabozantinib With Topotecan-CyclophosphamideCompletedNCT04661852Phase 1
• Intralesional Vitamin D in Alopecia AreataStatus unknownNCT04660786Phase 1/2
• Belimumab Treatment for IgG4-related DiseaseStatus unknownNCT04660565Phase 4
• Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer PatientsCompletedNCT04659551Phase 2
• Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSFCompletedNCT04658836Phase 1
• Bioequivalence Study of Fingolimod From Sphingomod 0.5 mg Hard Gelatin Capsules (Hikma Pharma, Egypt) Versus Gilenya 0.5 mg Hard Capsules (Novartis Pharma AG, Basle, Switzerland).CompletedNCT04657744Phase 1
• Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly PatientsTerminatedNCT04656262Phase 3
• Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.Active, not recruitingNCT04654988Phase 4
• CAR-T Cells for HIV InfectionActive, not recruitingNCT04648046Phase 1/2
• Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT04646356Phase 2
• A Study to Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's DiseaseWithdrawnNCT04643483Phase 3
• CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)Active, not recruitingNCT04637763Phase 1
• The Study of Pharmacokinetic Interactions Between HL237 and TacrolimusStatus unknownNCT04633733Phase 1
• Fingolimod in Endovascular Treatment of Ischemic StrokeStatus unknownNCT04629872Phase 2
• Rapamycin - Effects on Alzheimer's and Cognitive HealthActive, not recruitingNCT04629495Phase 2
• CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic LeukemiaStatus unknownNCT04626765Early Phase 1
• CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple MyelomaStatus unknownNCT04626752Early Phase 1
• CAR-T Cells in Treating Patients With Relapsed or Refractory NHLStatus unknownNCT04626739Early Phase 1
• Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT04626726Early Phase 1
• NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDSActive, not recruitingNCT04623944Phase 1
• Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS TuberculosisStatus unknownNCT04620772Phase 2/3
• Comparison of BTD and BCD Based Regimens in the Treatment of AL AmyloidosisStatus unknownNCT04612582Phase 4
• A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 2CompletedNCT04611971Phase 1
• Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS LymphomaActive, not recruitingNCT04609046Phase 1
• Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy VolunteersCompletedNCT04598542Phase 1
• Effect of Ciclosporin Eyedrops on Sjögren SyndromeCompletedNCT04597762Not applicable
• Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars)Status unknownNCT04593706Not applicable
• The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and ImmunotherapyActive, not recruitingNCT04591431Phase 2
• The Effectiveness and Safety of FK-506 for the Treatment of Posner-Schlossman SyndromeStatus unknownNCT04590183Not applicable
• Adalimumab Plus Methotrexate for the Treatment of Pediatric UveitisStatus unknownNCT04588818Phase 2
• Efficacy and Safety of Sirolimus in Active Systemic Lupus ErythematosusActive, not recruitingNCT04582136Phase 3
• Methotrexate in Erosive Inflammatory Hand OsteoarthritisActive, not recruitingNCT04579848Phase 4
• Corticosteroid and Repeated Dextrose Hydro-dissection for Carpal Tunnel Syndrome PatientsStatus unknownNCT04579783Not applicable
• ²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple MyelomaWithdrawnNCT04579523Phase 1
• Mesothelin-targeted CAR T-cell Therapy in Patients With MesotheliomaActive, not recruitingNCT04577326Phase 1
• Treatment of Pregnancy RAStatus unknownNCT04569890Not applicable
• Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic NeoplasiaActive, not recruitingNCT04562558Not applicable
• Study to Assess the Safety and Efficacy of Enbrel Administered by Sofusa DoseConnect for Rheumatoid ArthritisStatus unknownNCT04559412Phase 1
• Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCLTerminatedNCT04548700Phase 1
• A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological MalignanciesActive, not recruitingNCT04547049Phase 3
• Study of Edasalonexent With Midazolam and Deflazacort in Healthy SubjectsCompletedNCT04543370Phase 1
• The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation RecipientActive, not recruitingNCT04542733Not applicable
• Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy SubjectsCompletedNCT04542252Phase 1
• Tacrolimus as Treatment of Breast Cancer-Related LymphedemaCompletedNCT04541290Phase 1/2
• Cyclosporine A Plus Low-steroid Treatment in COVID-19 PneumoniaStatus unknownNCT04540926Phase 1/2
• Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST TrialSuspendedNCT04539366Phase 1
• Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal CancerCompletedNCT04534218Phase 2
• Comparison of Methylprednisolone or Methotrexate in the Maintenance Treatment of Nasal PolyposisCompletedNCT04532736Phase 2
• Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in AdultsActive, not recruitingNCT04530565Phase 3
• Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain CancerWithdrawnNCT04521946Phase 1
• Efficacy and Safety of Belimumab in SLE PatientsCompletedNCT04515719Phase 4
• Tear Film Markers in Dry Eye SyndromeWithdrawnNCT04515329Phase 4
• Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS LymphomaStatus unknownNCT04514393Phase 2
• MELD-ATG: Phase II, Dose Ranging, Efficacy Study of Anti-thymocyte Globulin (ATG) Within 6 Weeks of Diagnosis of Type 1 Diabetes (T1D)CompletedNCT04509791Phase 2
• Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy SubjectsCompletedNCT04498741Phase 1
• PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release TacrolimusCompletedNCT04496401Phase 4
• Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity StudyCompletedNCT04488601Phase 2
• I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill PatientsActive, not recruitingNCT04488081Phase 2
• Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA PatientsCompletedNCT04485325Phase 4
• Methotrexate Treatment of Arthritis Caused by Chikungunya Virus (MARCH)Active, not recruitingNCT04483466Phase 3
• Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDSWithdrawnNCT04482712Phase 1/2
• Repeated Methotrexate for Proliferative Vitreoretinopathy Grade CStatus unknownNCT04482543Phase 2/3
• Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell LymphomaActive, not recruitingNCT04480099Phase 2
• Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated LymphomaActive, not recruitingNCT04479267Phase 2
• Abatacept for Patients With COVID-19 and Respiratory DistressWithdrawnNCT04477642Phase 1/2
• Haplo Peripheral Blood Sct In GVHD PreventionCompletedNCT04473911Phase 1
• Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCACompletedNCT04470804Phase 4
• Tofacitinib Versus Methotrexate as the First Line DMARD in the Treatment of Rheumatoid ArthritisStatus unknownNCT04464642Phase 4
• Efficacy and Safety of Sirolimus in COVID-19 InfectionStatus unknownNCT04461340Phase 2
• Topical Steroids and Cyclosporin-A for COVID-19 KeratoconjunctivitisStatus unknownNCT04451239Not applicable
• Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform HemangioendotheliomaCompletedNCT04448873Phase 4
• VR-CAP in the First-line Treatment for Patients With Marginal Zone LymphomaCompletedNCT04433156Phase 2
• The Effect of Cyclosporin Before Cataract SurgeryCompletedNCT04426240Phase 4
• Multitarget Therapy for Idiopathic Membranous NephropathyCompletedNCT04424862Phase 4
• Comparison between2 Drugs in Lupus NephritisCompletedNCT04424602Phase 4
• Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS)WithdrawnNCT04415476Phase 2
• Cyclosporine in Patients With Moderate COVID-19CompletedNCT04412785Phase 1
• Modified SALT Score for Alopecia AreataStatus unknownNCT04412148Phase 4
• Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE)Active, not recruitingNCT04411654Phase 1/2
• Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese RMS Patients Treated With Teriflunomide 14 mg Once Daily for 24 WeeksCompletedNCT04410965Phase 4
• SCMC Trial on KHE With KMP (V.2020)Status unknownNCT04409691Phase 1
• Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia PatientsCompletedNCT04403321Phase 2
• An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC.Active, not recruitingNCT04395989Phase 2
• Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19CompletedNCT04392531Phase 4
• Iberdomide Combined With Low-dose Cyclophosphamide and DexamethasoneActive, not recruitingNCT04392037Phase 2
• Prevention of Breast Cancer-related Lymphedma With TacrolimusStatus unknownNCT04390685Phase 1/2
• TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic SclerosisActive, not recruitingNCT04380831Early Phase 1
• Surgery Alone Versus Methotrexate Before Surgery in Cesarean Scar PregnancyStatus unknownNCT04379219Phase 4
• Treatment of Corneal Infiltrates Secondary to Epidemic KeratoconjunctivitisCompletedNCT04376970Phase 4

← Immunosuppressive Agents overview